Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1987 Aug;40(8):909–913. doi: 10.1136/jcp.40.8.909

Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys.

J W Yarnell 1, P M Sweetnam 1, S Rogers 1, P C Elwood 1, D Bainton 1, I A Baker 1, R Eastham 1, J R O'Brien 1, M D Etherington 1
PMCID: PMC1141135  PMID: 3654991

Abstract

Data from two community studies on men from South Wales and the west of England suggest that the effects of smoking on the haemostatic system remain for many years after giving up. Long term correlations between several variables, including plasma fibrinogen and white cell count, and the length of time after giving up were seen in ex-smokers. Dose response relations were apparent in current smokers in terms of the white cell count and two haematological variables, the packed and mean cell volumes. These long term correlations probably reflect the toxicity of other agents in tobacco smoke besides nicotine and carbon monoxide, which act only in the short term. Identification of these agents may further our understanding of the mechanism by which cigarette smoking is associated with atherosclerotic disease.

Full text

PDF
909

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker I. A., Eastham R., Elwood P. C., Etherington M., O'Brien J. R., Sweetnam P. M. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J. 1982 May;47(5):490–494. doi: 10.1136/hrt.47.5.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CLAUSS A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 Apr;17(4):237–246. doi: 10.1159/000205234. [DOI] [PubMed] [Google Scholar]
  3. Galea G., Davidson R. J. Haematological and haemorheological changes associated with cigarette smoking. J Clin Pathol. 1985 Sep;38(9):978–984. doi: 10.1136/jcp.38.9.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harkness J. The viscosity of human blood plasma; its measurement in health and disease. Biorheology. 1971 Dec;8(3):171–193. doi: 10.3233/bir-1971-83-408. [DOI] [PubMed] [Google Scholar]
  5. Hartz A. J., Anderson A. J., Brooks H. L., Manley J. C., Parent G. T., Barboriak J. J. The association of smoking with cardiomyopathy. N Engl J Med. 1984 Nov 8;311(19):1201–1206. doi: 10.1056/NEJM198411083111901. [DOI] [PubMed] [Google Scholar]
  6. Hill P., Haley N. J., Wynder E. L. Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis. 1983;36(6):439–449. doi: 10.1016/0021-9681(83)90136-4. [DOI] [PubMed] [Google Scholar]
  7. Kannel W. B. Update on the role of cigarette smoking in coronary artery disease. Am Heart J. 1981 Mar;101(3):319–328. doi: 10.1016/0002-8703(81)90197-6. [DOI] [PubMed] [Google Scholar]
  8. Kaufman D. W., Helmrich S. P., Rosenberg L., Miettinen O. S., Shapiro S. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med. 1983 Feb 24;308(8):409–413. doi: 10.1056/NEJM198302243080801. [DOI] [PubMed] [Google Scholar]
  9. Kolars J. C., Levitt M. D., Aouji M., Savaiano D. A. Yogurt--an autodigesting source of lactose. N Engl J Med. 1984 Jan 5;310(1):1–3. doi: 10.1056/NEJM198401053100101. [DOI] [PubMed] [Google Scholar]
  10. Lewis G. P., Jusko W. J., Coughlin L. L. Cadmium accumulation im man: influence of smoking, occupation, alcoholic habit and disease. J Chronic Dis. 1972 Dec;25(12):717–726. doi: 10.1016/0021-9681(72)90007-0. [DOI] [PubMed] [Google Scholar]
  11. Lowe G. D., Drummond M. M., Forbes C. D., Barbenel J. C. The effects of age and cigarette-smoking on blood and plasma viscosity in men. Scott Med J. 1980 Jan;25(1):13–17. doi: 10.1177/003693308002500103. [DOI] [PubMed] [Google Scholar]
  12. McGill H. C., Jr Potential mechanisms for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. Prev Med. 1979 May;8(3):390–403. doi: 10.1016/0091-7435(79)90016-1. [DOI] [PubMed] [Google Scholar]
  13. Meade T. W., Chakrabarti R., Haines A. P., North W. R., Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979 Jan 20;1(6157):153–156. doi: 10.1136/bmj.1.6157.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  15. O'Brien J. R., Etherington M., Jamieson S., Lawford P., Sussex J., Lincoln S. V. Heparin neutralizing activity test in the diagnosis of acute myocardial infarction. J Clin Pathol. 1975 Dec;28(12):975–979. doi: 10.1136/jcp.28.12.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pilgeram L. O. Turnover rate of autologous plasma fibrinogen-14C in subjects with coronary thrombosis. Thromb Diath Haemorrh. 1968 Nov 15;20(1):31–43. [PubMed] [Google Scholar]
  17. Reid D. D., Hamilton P. J., McCartney P., Rose G., Jarrett R. J., Keen H. Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet. 1976 Nov 6;2(7993):979–984. doi: 10.1016/s0140-6736(76)90830-8. [DOI] [PubMed] [Google Scholar]
  18. Thorp J. M., Horsfall G. B., Stone M. C. A new red-sensitive micronephelometer. Med Biol Eng. 1967 Jan;5(1):51–56. doi: 10.1007/BF02478842. [DOI] [PubMed] [Google Scholar]
  19. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]
  20. Yarnell J. W., Fehily A. M., Milbank J., Kubicki A. J., Eastham R., Hayes T. M. Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J Epidemiol Community Health. 1983 Jun;37(2):137–140. doi: 10.1136/jech.37.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yarnell J. W., Sweetnam P. M., Elwood P. C., Eastham R., Gilmour R. A., O'Brien J. R., Etherington M. D. Haemostatic factors and ischaemic heart disease. The Caerphilly study. Br Heart J. 1985 May;53(5):483–487. doi: 10.1136/hrt.53.5.483. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES